Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal adenocarcinoma.
Atri P, Shah A, Natarajan G, Rachagani S, Rauth S, Ganguly K, Carmicheal J, Ghersi D, Cox JL, Smith LM, Jain M, Kumar S, Ponnusamy MP, Seshacharyulu P, Batra SK. Atri P, et al. Among authors: seshacharyulu p. NPJ Precis Oncol. 2024 Mar 7;8(1):66. doi: 10.1038/s41698-024-00562-5. NPJ Precis Oncol. 2024. PMID: 38454151 Free PMC article.
Understanding the role of Pax5 in development of taxane-resistant neuroendocrine like prostate cancers.
Dutta S, Bhattacharya S, Harris H, Islam R, Bodas S, Polavaram N, Mishra J, Das D, Seshacharyulu P, Kalluchi A, Pal A, Kohli M, Lele S, Muders M, Batra S, Ghosh P, Datta K, Rowley M. Dutta S, et al. Among authors: seshacharyulu p. Res Sq [Preprint]. 2023 Dec 11:rs.3.rs-3464475. doi: 10.21203/rs.3.rs-3464475/v1. Res Sq. 2023. PMID: 38168280 Free PMC article. Preprint.
ASPORIN: A root of the matter in tumors and their host environment.
Lall SP, Alsafwani ZW, Batra SK, Seshacharyulu P. Lall SP, et al. Among authors: seshacharyulu p. Biochim Biophys Acta Rev Cancer. 2024 Jan;1879(1):189029. doi: 10.1016/j.bbcan.2023.189029. Epub 2023 Nov 24. Biochim Biophys Acta Rev Cancer. 2024. PMID: 38008263 Review.
Targeting the EGFR signaling pathway in cancer therapy: What's new in 2023?
Halder S, Basu S, Lall SP, Ganti AK, Batra SK, Seshacharyulu P. Halder S, et al. Among authors: seshacharyulu p. Expert Opin Ther Targets. 2023 Apr-May;27(4-5):305-324. doi: 10.1080/14728222.2023.2218613. Epub 2023 Jun 2. Expert Opin Ther Targets. 2023. PMID: 37243489 Free PMC article. Review.
MUC16 promotes triple-negative breast cancer lung metastasis by modulating RNA-binding protein ELAVL1/HUR.
Chaudhary S, Appadurai MI, Maurya SK, Nallasamy P, Marimuthu S, Shah A, Atri P, Ramakanth CV, Lele SM, Seshacharyulu P, Ponnusamy MP, Nasser MW, Ganti AK, Batra SK, Lakshmanan I. Chaudhary S, et al. Among authors: seshacharyulu p. Breast Cancer Res. 2023 Mar 14;25(1):25. doi: 10.1186/s13058-023-01630-7. Breast Cancer Res. 2023. PMID: 36918912 Free PMC article.
Small molecule inhibitor against onco-mucins disrupts Src/FosL1 axis to enhance gemcitabine efficacy in pancreatic ductal adenocarcinoma.
Zhang C, Atri P, Nallasamy P, Parte S, Rauth S, Nimmakayala RK, Marimuthu S, Chirravuri-Venkata R, Bhatia R, Halder S, Shah A, Cox JL, Smith L, Kumar S, Foster JM, Kukreja RC, Seshacharyulu P, Ponnusamy MP, Batra SK. Zhang C, et al. Among authors: seshacharyulu p. Cancer Lett. 2022 Dec 28;551:215922. doi: 10.1016/j.canlet.2022.215922. Epub 2022 Sep 19. Cancer Lett. 2022. PMID: 36285687 Free PMC article.
Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma.
Lakshmanan I, Marimuthu S, Chaudhary S, Seshacharyulu P, Rachagani S, Muniyan S, Chirravuri-Venkata R, Atri P, Rauth S, Nimmakayala RK, Siddiqui JA, Gautam SK, Shah A, Natarajan G, Parte S, Bhyravbhatla N, Mallya K, Haridas D, Talmon GA, Smith LM, Kumar S, Ganti AK, Jain M, Ponnusamy MP, Batra SK. Lakshmanan I, et al. Among authors: seshacharyulu p. Oncogene. 2022 Nov;41(48):5147-5159. doi: 10.1038/s41388-022-02493-6. Epub 2022 Oct 21. Oncogene. 2022. PMID: 36271032 Free PMC article.
DNA-gold nanoprobe-based integrated biosensing technology for non-invasive liquid biopsy of serum miRNA: A new frontier in prostate cancer diagnosis.
Kshirsagar P, Seshacharyulu P, Muniyan S, Rachagani S, Smith LM, Thompson C, Shah A, Mallya K, Kumar S, Jain M, Batra SK. Kshirsagar P, et al. Among authors: seshacharyulu p. Nanomedicine. 2022 Jul;43:102566. doi: 10.1016/j.nano.2022.102566. Epub 2022 May 13. Nanomedicine. 2022. PMID: 35569810 Free PMC article.
50 results